secwatch.observer — SEC 8-K summary
======================================

Issuer:     Roivant Sciences Ltd. (ROIV)
CIK:        0001635088
Form:       8-K
Filed at:   2025-09-11T23:59:59+00:00
Accession:  0001140361-25-034711
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Roivant Sciences shareholders re-elect three directors, ratify auditor, approve say-on-pay at 2025 AGM
--------------------------------------------------------------------------------

- Matthew Gline, Keith Manchester, Melissa Epperly re-elected as Class I directors; each received >72% of votes cast excluding broker non-votes.
- Ratification of Ernst & Young as independent auditor for FY2026: 628M for, 479K against, 125K abstain.
- Non-binding say-on-pay approved: 316.7M for, 203.2M against, 64.6M abstain, 44.2M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1635088/000114036125034711/0001140361-25-034711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1635088/000114036125034711/ef20055421_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-034711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer